|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/70 |
| (11) | Number of the document | 2136795 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08726714.2 |
| Date of filing the European patent application | 2008-03-11 | |
| (97) | Date of publication of the European application | 2009-12-30 |
| (45) | Date of publication and mention of the grant of the patent | 2013-09-04 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/003221 |
| Date | 2008-03-11 |
| (87) | Number | WO 2008/115371 |
| Date | 2008-09-25 |
| (30) | Number | Date | Country code |
| 725159 | 2007-03-16 | US |
| (72) |
TANG, Jiansheng, US
DEVERICH, Joseph, M., US
MILLER, Kenneth, J., II., US
BESTE, Russell, D., US
|
| (73) |
MYLAN TECHNOLOGIES, INC.,
110 Lake Street, St. Albans, VT 05478,
US
|
| (54) | AMORPHOUS DRUG TRANSDERMAL SYSTEMS, MANUFACTURING METHODS, AND STABILIZATION |
| AMORPHOUS DRUG TRANSDERMAL SYSTEMS, MANUFACTURING METHODS, AND STABILIZATION |